Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Tuğba Akın Telli (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation
Assoc. Prof. Tuğba Akın Telli, M.D. is a seasoned clinical oncologist based in Istanbul, Turkey, with over 16 years of experience in medical oncology. Currently practicing at Istanbul Florence Nightingale Hospital, she specializes in:
- Breast cancer
- Colorectal cancer
- Gastrointestinal cancers
- Immunotherapy and targeted therapies
Educational Background
- Medical Degree: Akdeniz University Faculty of Medicine, Turkey (2003–2008)
- Internal Medicine Residency: Hacettepe University Faculty of Medicine (2009–2014)
- Medical Oncology Fellowship: Marmara University Faculty of Medicine, Department of Medical Oncology (2016–2019)
- Observerships:
- MD Anderson Cancer Center, USA (2013–2014)
- Bellvitge Hospital, Barcelona, Spain (2013)
- Clinical Research Fellowship: Institut Jules Bordet, Brussels, Belgium (2019 and 2021–2022)
Professional Experience
- Present: Istanbul Florence Nightingale Hospital – Medical Oncology
- 2022–2024: Memorial Şişli Hospital – Medical Oncology Specialist
- 2020–2022: Marmara University Pendik Training and Research Hospital – Medical Oncology Specialist
- 2014–2016: Golbasi Public Hospital – Internal Medicine Specialist
Academic Contributions
- Associate Professor of Medical Oncology
- Active involvement in clinical research, particularly in gastrointestinal and breast cancers
- Mentorship roles for medical students and residents
- Participation in international oncology conferences and symposiums
Areas of Expertise
Dr. Akın Telli’s clinical expertise encompasses a range of oncological conditions, including:
- Breast Cancer: Management of early-stage and metastatic cases with personalized treatment plans
- Colorectal Cancer: Utilization of advanced therapies for improved patient outcomes
- Gastrointestinal Cancers: Comprehensive care for various GI malignancies
- Immunotherapy: Application of immune checkpoint inhibitors in suitable cases
Publications and Research
Dr. Akın Telli has contributed to several peer-reviewed journals, with notable publications including:
- Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer – Cancers, 2023
- Regorafenib in Combination with Immune Checkpoint Inhibitors for MSS Colorectal Cancer – Cancer Treatment Reviews, 2022
- Prediction of Nipple Involvement in Breast Cancer After Neoadjuvant Chemotherapy – Breast Cancer Research and Treatment, 2023
Her research focuses on enhancing treatment efficacy and patient quality of life through innovative therapeutic approaches.
Patient Care Philosophy
- Emphasizes personalized treatment plans tailored to individual patient needs
- Advocates for clear communication and patient education throughout the treatment journey
- Offers online consultations to accommodate international patients
- Committed to cultural sensitivity and ensuring patient comfort and satisfaction
Professional Affiliations
- Member of the European Society for Medical Oncology (ESMO)
- Member of the American Society of Clinical Oncology (ASCO)
- Member of the Turkish Medical Oncology Association
FAQs
- Is Dr. Tuğba Akın Telli board-certified?
- Yes, she holds board certifications in both Internal Medicine and Medical Oncology.
- What types of treatments does she offer?
- Dr. Akın Telli provides comprehensive oncology care, including chemotherapy, immunotherapy, and targeted therapies for various cancers.
- Does she treat international patients?
- Yes, she offers online consultations and treatment plans for international patients.
- How long is the typical hospital stay for oncology treatments?
- Hospital stays vary depending on the treatment regimen; some therapies are administered on an outpatient basis, while others may require short-term hospitalization.
- What languages does she speak?
- Dr. Akın Telli is fluent in English, German, and Turkish.
Patient reviews
Patient reviews
